CABA Cabaletta Bio, Inc: Earnings per share for the last twelve months

Official company branding of Cabaletta Bio, Inc. (CABA)

Cabaletta Bio, Inc. (CABA) is developing advanced targeted cell therapy methods in the US to combat autoimmune malfunctions. This daily chart from GURU.Markets illustrates the rolling 12-month net income per share, where the -1.44 level serves as a critical benchmark. Cabaletta Bio, Inc. (CABA) focuses on curing lupus and pemphigus via B-cells, with the results of Phase I and II CAR-T therapy trials poised to be the immediate growth drivers.

Cabaletta Bio, Inc. (CABA) - Net earnings per share (EPS TTM) from 07/04/2022 to 11/11/2026

Analytical breakdowns and data insights for company Cabaletta Bio Inc. (CABA)

- current quotes and average value forecast:
Price Chart Cabaletta Bio, Inc.|CABA - Consensus Target
- company stock capitalization data:
Market Value Cabaletta Bio|CABA - Real Price to Acquire Entire Company
- shareholders' equity book value data:
Accounting Value per Share Cabaletta Bio, Inc.|CABA - Book Capitalization|Market Value to Book Value Ratio cabalettabio.com|CABA - Total Business Assets
- debt and liquidity data:
Total Debt to Capital Cabaletta Bio, Inc.|CABA - Long-Term Liabilities to Capital|Short-Term Debt to Capital Cabaletta Bio, Inc|CABA - Company Total Debt|Debts to Book Capitalization Cabaletta Bio|CABA - Company Long-Term Debts|Company Short-Term Debts Cabaletta Bio, Inc.|Quick Ratio cabalettabio.com
- earnings and valuation multiples indicators:
CABA - Net Profit|Expected Profit Cabaletta Bio, Inc.|CABA - Price to Earnings Ratio|Forward P/E Multiple Cabaletta Bio|CABA - Price to Earnings Adjusted for Growth Rate|Enterprise Value to EBITDA Ratio Cabaletta Bio|CABA - Company profit before taxes, interest and amortization|Net earnings per share for the last 12 months Cabaletta Bio, Inc.|CABA - Earnings per share for the last four quarters|Quarterly EPS earnings growth cabalettabio.com|CABA - Earnings growth in current year|Expected earnings per share growth for next year Cabaletta Bio, Inc.
Initial company analysis:Cabaletta Bio, Inc. (CABA)
Manufactured products of Cabaletta Bio Inc.

To assess long-term risks, an investor analyzes EPS TTM as the ratio of total annual net income to the number of shares, which allows them to filter out noise and identify the actual efficiency of capital management. This daily price chart of net income per share over 12 months reflects the financial stability of Cabaletta Bio, Inc. (CABA) during the costly clinical trials of the CABA-201 platform and its expansion into the immunotherapy market.

Competitors of Cabaletta Bio, Inc. (CABA)

ARGX - Earnings per share for the last twelve months|biontech.de (BNTX) - Net earnings per share for the last 12 months|Abivax Pharma (ABVX) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months ADMA Biologics Inc|Net earnings per share for the last 12 months PTGX|Net earnings per share (EPS TTM) Immunovant Therapeutics|Earnings per share for the last twelve months Kiniksa Pharmaceuticals (KNSA)|grifols.com - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) ADPT (Adaptive Biotechnologies Corporation)|Celldex Therapeutics Inc (CLDX) - Net earnings per one share for the last twelve months|Aurinia Pharma - Net earnings per share (EPS TTM)|BioCryst Corp (BCRX) - Net earnings per share for the last 12 months|VERA: Net earnings per share (EPS TTM)|dianthustx.com (DNTH) - Net earnings per share (EPS TTM)|PHVS (Pharvaris) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months ABCL|Net earnings per share (EPS TTM) TRML|Net earnings per share (EPS TTM) Precigen Corp (PGEN)|Earnings per share for the last twelve months Pharming Group N.V. PHAR|nektar.com - Earnings per share for the last twelve months|Upstream Bio - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Zenas Bio|IMNM (Immunome Corp) - Net earnings per share for the last 12 months|GOSS: Earnings per share for the last four quarters|Net earnings per share for the last 12 months KALV|SEPN (septerna.com) - Earnings per share for the last four quarters|Net earnings per share (EPS TTM) PVLA|Net earnings per share (EPS TTM) Savara Inc (SVRA)|Rigel Pharmaceuticals Inc - Net earnings per share for the last 12 months|Earnings per share for the trailing year ANAB|Astria Therapeutics - Net earnings per share (EPS TTM)|ENGN: Earnings per share for the last twelve months|RAPT: Net earnings per share (EPS TTM)|JBIO - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Aclaris|Net earnings per one share for the last twelve months Kyverna Therapeutics, Inc KYTX|Net earnings per share for the last 12 months TLSA (Tiziana Life Sciences)|VTYX (ventyxbio.com) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) THTX (Theratechnologies)|Net earnings per share for the last four quarters Avalo Therapeutics, Inc. (AVTX)|ELDN - Earnings per share for the last twelve months|AGEN (Agenus, Inc) - Earnings per share for the last 12 months|CLYM: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Zura Bio Ltd|Net earnings per share for the last 12 months ATYR|Adagene Corp (ADAG) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) IMA|Net earnings per share for the last 12 months shattucklabs.com STTK|Net earnings per share (EPS TTM) EQ (Equillium)|Net earnings per share (EPS TTM) Connect Biopharma Holdings CNTB|Immunic Inc - Net earnings per share (EPS TTM)|ATRA: Earnings per share for the last twelve months|IFRX: Net earnings per share (EPS TTM)|X4 Pharmaceuticals, Inc (XFOR) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Adicet Bio Inc.|Celularity Corp - Earnings per one share for the last 12 months|Net earnings per share (EPS TTM) INMB|BRNS (Barinthus Biotherapeutics PLC) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) KZR (Kezar Life Sciences, Inc)|Net earnings per share (EPS TTM) SAB Biotherapeutics Inc SABS|AKTX - Earnings per share for the last twelve months|Earnings per share for the trailing year ENLV (Enlivex Therapeutics)|q32bio.com (QTTB) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months GeoVax Labs|EDSA (Edesa) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) iBio Corporation|Net earnings per share for the last 12 months CARM (Carisma Therapeutics)|XTLB (xtlbio.com) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) BOLT (Bolt Biotherapeutics, Inc.)|Net earnings per share for the last four quarters HCW Biologics, Inc. (HCWB)|APVO - Earnings per share for the last twelve months|AIM ImmunoTech, Inc. (AIM) - Net earnings per share for the last 12 months|aditxt.com (ADTX) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months gribio.com|Net earnings per share for the last 12 months XRTX|Net earnings per share (EPS TTM) Vyome Holdings Inc.|Earnings per share for the last twelve months Revelation Bio (REVB)|Indaptus Corp - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) SCNI (Scinai Immunotherapeutics)|CalciMedica Inc (CALI) - Net earnings per one share for the last twelve months|Affimed Therapeutics - Net earnings per share (EPS TTM)|Allakos Inc. (ALLK) - Net earnings per share for the last 12 months|HOOK: Net earnings per share (EPS TTM)|IGM Biosciences (IGMS) - Net earnings per share (EPS TTM)|ITOS (iTeos Therapeutics) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months OCEA|Net earnings per share (EPS TTM) TCBP|Net earnings per share (EPS TTM) Third Harmonic Bio Inc. (THRD)